Free Trial

PCM Fund (PCM) Competitors

PCM Fund logo
$7.71 +0.04 (+0.52%)
(As of 12/20/2024 04:33 PM ET)

PCM vs. HQL, MIY, ASG, SAR, MHN, MIN, TPVG, AEF, MMT, and MXF

Should you be buying PCM Fund stock or one of its competitors? The main competitors of PCM Fund include Abrdn Life Sciences Investors (HQL), BlackRock MuniYield Michigan Quality Fund (MIY), Liberty All-Star Growth Fund (ASG), Saratoga Investment (SAR), BlackRock MuniHoldings New York Quality Fund (MHN), MFS Intermediate Income Trust (MIN), TriplePoint Venture Growth BDC (TPVG), Abrdn Emerging Markets Equity Income Fund (AEF), MFS Multimarket Income Trust (MMT), and The Mexico Fund (MXF). These companies are all part of the "financial services" industry.

PCM Fund vs.

Abrdn Life Sciences Investors (NYSE:HQL) and PCM Fund (NYSE:PCM) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability, earnings and community ranking.

Abrdn Life Sciences Investors pays an annual dividend of $1.86 per share and has a dividend yield of 13.8%. PCM Fund pays an annual dividend of $0.96 per share and has a dividend yield of 12.5%.

In the previous week, PCM Fund had 1 more articles in the media than Abrdn Life Sciences Investors. MarketBeat recorded 1 mentions for PCM Fund and 0 mentions for Abrdn Life Sciences Investors. PCM Fund's average media sentiment score of 0.64 beat Abrdn Life Sciences Investors' score of 0.00 indicating that PCM Fund is being referred to more favorably in the news media.

Company Overall Sentiment
Abrdn Life Sciences Investors Neutral
PCM Fund Positive

Abrdn Life Sciences Investors has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500. Comparatively, PCM Fund has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abrdn Life Sciences Investors$86.69M4.26N/AN/AN/A
PCM Fund$5.49M16.88N/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Abrdn Life Sciences InvestorsN/A N/A N/A
PCM Fund N/A N/A N/A

32.2% of Abrdn Life Sciences Investors shares are owned by institutional investors. Comparatively, 10.3% of PCM Fund shares are owned by institutional investors. 10.1% of Abrdn Life Sciences Investors shares are owned by company insiders. Comparatively, 1.0% of PCM Fund shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

PCM Fund received 92 more outperform votes than Abrdn Life Sciences Investors when rated by MarketBeat users. Likewise, 71.10% of users gave PCM Fund an outperform vote while only 68.35% of users gave Abrdn Life Sciences Investors an outperform vote.

CompanyUnderperformOutperform
Abrdn Life Sciences InvestorsOutperform Votes
95
68.35%
Underperform Votes
44
31.65%
PCM FundOutperform Votes
187
71.10%
Underperform Votes
76
28.90%

Summary

PCM Fund beats Abrdn Life Sciences Investors on 6 of the 10 factors compared between the two stocks.

Get PCM Fund News Delivered to You Automatically

Sign up to receive the latest news and ratings for PCM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PCM vs. The Competition

MetricPCM FundInvestment offices IndustryFinance SectorNYSE Exchange
Market Cap$92.61M$8.38B$10.99B$19.18B
Dividend Yield12.15%6.75%9.85%3.59%
P/E RatioN/A0.4428.5441.28
Price / Sales16.8814.6548.6117.59
Price / CashN/A7.0330.3421.28
Price / BookN/A0.882.735.32
Net IncomeN/A$73.96M$1.03B$989.88M
7 Day Performance-3.38%-2.96%-2.89%-3.54%
1 Month Performance-3.62%-2.31%-2.86%-3.68%
1 Year Performance-2.90%3.73%11.28%12.14%

PCM Fund Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PCM
PCM Fund
N/A$7.71
+0.5%
N/A-5.3%$92.61M$5.49M0.00N/ANews Coverage
HQL
Abrdn Life Sciences Investors
N/A$13.81
-0.2%
N/A+4.0%$377.70MN/A0.00N/A
MIY
BlackRock MuniYield Michigan Quality Fund
N/A$11.67
+0.2%
N/A-0.4%$342.69M$18.58M0.00N/A
ASG
Liberty All-Star Growth Fund
N/A$5.85
+0.3%
N/A+8.7%$340.69M$37.15M0.00N/APositive News
SAR
Saratoga Investment
1.6532 of 5 stars
$24.25
+0.7%
$25.42
+4.8%
-6.7%$334.65M$143.72M15.743,211News Coverage
MHN
BlackRock MuniHoldings New York Quality Fund
N/A$10.66
+0.1%
N/A-3.2%$322.36MN/A0.00N/A
MIN
MFS Intermediate Income Trust
N/A$2.71
flat
N/A-3.6%$308.40MN/A0.00N/AEx-Dividend
TPVG
TriplePoint Venture Growth BDC
0.9795 of 5 stars
$7.22
-8.0%
$7.70
+6.6%
-31.5%$289.15M$24.23M34.76N/AHigh Trading Volume
AEF
Abrdn Emerging Markets Equity Income Fund
N/A$5.46
-0.2%
N/A+7.6%$277.11M$26.30M0.00N/A
MMT
MFS Multimarket Income Trust
N/A$4.72
-0.4%
N/A+1.5%$261.03M$20.10M0.00N/AEx-Dividend
Positive News
MXF
The Mexico Fund
N/A$13.94
-1.1%
N/A-26.1%$259.33M$35.10M0.00N/ADividend Announcement
News Coverage

Related Companies and Tools


This page (NYSE:PCM) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners